European Registry on <i>Helicobacter pylori</i> management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice

Abstract

Single-capsule bismuth quadruple therapy achieved H. pylori eradication in approximately 90% of patients in real-world clinical practice, both as a first-line and rescue treatment, with good compliance and a favourable safety profile.